ISA Pharmaceuticals BV:
ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology. SLP®immunotherapies are designed to fully harness and direct the body’s own defenses towards fighting the disease.
Phase III, Phase l or ll
Anti-infectives, Antivirals, Infectious Disease, Oncology
100MM - 500MM
Antibodies, Cell Therapy
J.H. Oortweg 19-21
Leiden, 2333 CH
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Summer 2020 NYC Private Company Showcase
New York, NY,
August 10, 2020